Hans Lennart Rudolf Wigzell
Président chez RAYSEARCH LABORATORIES AB
Fortune : 3 M $ au 30/04/2024
Postes actifs de Hans Lennart Rudolf Wigzell
Sociétés | Poste | Début | Fin |
---|---|---|---|
RAYSEARCH LABORATORIES AB | Independent Dir/Board Member | 01/05/2004 | - |
Président | 30/09/2022 | - | |
Directeur/Membre du Conseil | 01/05/2004 | 30/09/2022 | |
SAREPTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2010 | - |
Independent Dir/Board Member | 06/07/2012 | - | |
Wigzellproduktion AB | Directeur/Membre du Conseil | - | - |
Biochromix Newco AB | Président | - | - |
PRFA Management AB | Président | - | - |
Karolinska Institutet | Président | 01/01/2003 | - |
President | 01/01/1995 | 01/01/2003 | |
Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal | - | - |
Stockholm School of Entrepreneurship | Président | - | - |
European Molecular Biology Organization | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Historique de carrière de Hans Lennart Rudolf Wigzell
Anciens postes connus de Hans Lennart Rudolf Wigzell
Sociétés | Poste | Début | Fin |
---|---|---|---|
░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Hans Lennart Rudolf Wigzell
Karolinska Institutet | Doctorate Degree |
Statistiques
Internationale
Suède | 22 |
Etats-Unis | 4 |
France | 3 |
Opérationnelle
Director/Board Member | 15 |
Corporate Officer/Principal | 8 |
Chairman | 8 |
Sectorielle
Health Technology | 12 |
Commercial Services | 5 |
Finance | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 7 |
---|---|
RAYSEARCH LABORATORIES AB | Technology Services |
PROBI AB | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
VALNEVA | Health Technology |
NEOS AB | Health Technology |
Entreprise privées | 21 |
---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
Humabs LLC
Humabs LLC BiotechnologyHealth Technology Humabs LLC is a biotechnology company that operates in the field of biotechnology. The private company is based in Burlingame, CA. | Health Technology |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Commercial Services |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
Finnish Society of Sciences & Letters | |
Smittskyddsinstitutet | |
European Molecular Biology Organization | |
Mertiva AB
Mertiva AB Financial ConglomeratesFinance Mertiva AB engages in owning, managing, acquiring, and trading of securities and other properties. The company is headquartered in Danderyd, Sweden. | Finance |
Wigzellproduktion AB | |
ExThera AB
ExThera AB Pharmaceuticals: MajorHealth Technology ExThera AB commercializes medical products. manufactures medical products in both in vitro and in vivo studies. Its products include Ekoral-S the biocompatible mouth-rinse, ExT-M for treatment of oral mucositis, meeting unmet medical needs, and pipeline of additional new products. The company was founded by Karl Olov Peter Larm in 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
Royal Danish Academy of Sciences & Letters | |
Cadila Pharmaceuticals Sweden AB | Health Technology |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Finance |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |
PRFA Management AB | |
Biochromix Newco AB | |
National Bacteriological Laboratory | |
Gapminder Foundation
Gapminder Foundation Data Processing ServicesTechnology Services Gapminder Foundation provides data online on trends and statistics. The company was founded by Ola Rosling, Anna Rosling Rönnlund and Hans Roslin on February 25, 2005 and is headquartered in Stockholm, Sweden. | Technology Services |